Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest Clinical Trials & Medical Discoveries

06:00 BST Shire Announces EMA Validation of Veyvondi[TM] [Von Willebrand Factor (Recombinant)] Marketing Authorization Application for Treatment of Von Willebrand Disease

VEYVONDI is the first and only recombinant von Willebrand factor treatment for adults with von Willebrand disease, the most common inherited...


21 Jun, 2017, 14:30 BST Advicenne to Present Preliminary Phase III Clinical Data on ADV7103 at the Upcoming European Society of Paediatric Nephrology's Annual Meeting

Advicenne, a late-stage biopharmaceutical company focused on the development of paediatric-friendly therapeutics for the treatment of orphan renal...


21 Jun, 2017, 14:00 BST Roche receives CE mark for CMV viral load testing on cobas® 4800 System

- CMV is the most common and serious viral infection in transplant patients - The cobas® CMV test provides reliable, reproducible, high-quality...


21 Jun, 2017, 13:13 BST InDex Pharmaceuticals Enrolls First Patient in the Phase IIb Study CONDUCT With Cobitolimod

InDex Pharmaceuticals Holding AB (publ) today announced that the first patient has been enrolled in the clinical study CONDUCT – a phase IIb dose...


21 Jun, 2017, 11:50 BST Mylan at the EAACI Annual Congress 2017 - The Allergic Rhinitis Challenge: Perception and Control

The global respiratory community has met at the EAACI Annual Congress 2017 in Helsinki, during which Mylan sponsored an interactive symposium to...


21 Jun, 2017, 08:00 BST Menarini Ricerche to Present the Most Recent Data About the Pre-clinical Development of its Novel ADC MEN1309/OBT076 at the 29th Pezcoller Symposium

Menarini Ricerche and the UK company Oxford BioTherapeutics (OBT) will present the latest data about their novel antibody drug-conjugate (ADC)...


20 Jun, 2017, 19:42 BST Study: SEM Scanner Detects Bedsores Before Visual Diagnosis

BBI's Device Takes Aim at £2.1bn Public Health Problem A wireless handheld scanner detected bedsores developing under the skin earlier than...


20 Jun, 2017, 16:00 BST Almac Discovery and Debiopharm International SA Announce a Licensing Agreement for the Development of a Novel Wee-1 Inhibitor

Almac Discovery (http://www.almacgroup.com/discovery), a biopharmaceutical company focused on discovering and identifying innovative therapeutics...


20 Jun, 2017, 14:05 BST Data Presentations at European Hematology Association (EHA) 22nd Annual Congress Further Validate SkylineDx Prognostic Tools in Multiple Myeloma

Posters Reinforce Value of MMprofiler™ Gene-based Prognostic Signature for: - Identifying High-Risk Elderly Patients - TOPSPIN Algorithm for...


20 Jun, 2017, 10:00 BST ALK Symposium Reveals Early Treatment is Critical for Respiratory Allergic Disease in Children and Adolescents

- Allergic rhinitis has a major impact on children's quality of life - Children with allergic rhinitis have an increased risk of...


20 Jun, 2017, 00:01 BST New Medical Cannabis Joint Venture: LeafCann and iCAN: Israel-Cannabis Form iCAN:Australia

Agreement Paves Way for Significant Israel-Australia Medical Cannabis Collaboration iCAN: Israel-Cannabis (iCAN), a leading Israeli developer of...


20 Jun, 2017, 00:01 BST Cell and Gene Therapy Catapult Announces Cell Medica Acquisition of WT1 T-cell Therapy

Acquisition transfers intellectual property and commercialisation rights to promising cancer immunotherapy Further development will take place...


19 Jun, 2017, 06:30 BST First real-world evidence shows long term benefits of sublingual immunotherapy to control allergic rhinitis and potentially prevent allergic asthma

- Allergic rhinitis is a common, chronic, and often debilitating condition that impacts approximately 500 million people globally(1), putting these...


16 Jun, 2017, 06:00 BST Eli Lilly and Company: RA Matters Survey Uncovers What Matters Most to Over 5,000 People Living With Rheumatoid Arthritis

Through interactive data visualization, RA Matters allows the RA community to see and compare the results of the survey in real time:...


15 Jun, 2017, 13:00 BST Debiopharm International SA Announces Completion of Enrollment in Phase I/II Clinical Trial with Debio 1143 in SCCHN

A total of 96 patients randomized in France and Switzerland. Results expected in Q1 2019. Debiopharm International SA (Debiopharm -...


15 Jun, 2017, 06:00 BST LEO Pharma Starts Phase 3 Clinical Study for Tralokinumab in Atopic Dermatitis

LEO Pharma today announced that the first patients have been dosed in a phase 3 clinical study of tralokinumab. Tralokinumab is an...


14 Jun, 2017, 23:01 BST AbbVie Presents Real-World Data Evaluating the Relationship between Participation in a Patient Support Program and Outcomes in Patients with Moderate to Severe Rheumatoid Arthritis

- New data of rheumatoid arthritis patients who participated in a HUMIRA (adalimumab) patient support program in select countries showed an...


14 Jun, 2017, 11:38 BST Single Dose Betalutin® Continues to Show Promising Efficacy and Safety in Recurrent Indolent NHL Patients

Nordic Nanovector ASA (OSE: NANO) announces that updated results from its ongoing LYMRIT 37-01 Phase 1/2 clinical trial of Betalutin®...


13 Jun, 2017, 23:01 BST Results from CRIB study on CIMZIA® (certolizumab pegol) demonstrate minimal to no placental transfer of drug from mother to infant during third trimester of pregnancy

-- First-of-its-kind CRIB study used a sensitive and specific assay designed to detect CIMZIA and found minimal to no placental transfer from...


13 Jun, 2017, 12:05 BST New Study Shows Patients Treated With CroFab® Have Improved Recovery From Copperhead Envenomation

A study sponsored by BTG plc (LSE: BTG), the global specialist healthcare company, has been recently published in the Annals of Emergency...


13 Jun, 2017, 10:00 BST PharmaMar Announces Encouraging Results in Clinical Trials of Lurbinectedin in Endometrial and Breast Cancers

PharmaMar (MCE: PHM) has participated in the Annual Meeting of the American society of Clinical Oncology (ASCO) with new data with inhibitors of...


13 Jun, 2017, 09:00 BST mindBEAGLE: The first EEG-based BCI System Ever for Communication with Complete Locked-in Patients

Frontiers in Neuroscience recently published an article presenting mindBEAGLE as the very first and only EEG-based Brain-Computer Interface (BCI)...


13 Jun, 2017, 06:21 BST Nordic Nanovector - Invitation to Conference Call for Updated Clinical Trial Results Reported at the International Conference on Malignant Lymphoma

Nordic Nanovector ASA (OSE: NANO) will host a conference call on Wednesday, 14 June at 1 pm CET to present updated results from its ongoing LYMRIT...


13 Jun, 2017, 02:30 BST New LEADER Analysis Shows Victoza® Reduces Cardiovascular Risk in People With Type 2 Diabetes Regardless of Severe Hypoglycaemia Events

Findings from a post hoc analysis of the LEADER cardiovascular (CV) outcomes trial showed that treatment with Victoza® (liraglutide) resulted in...


13 Jun, 2017, 00:01 BST Amgen's Multiple Myeloma Treatment, KYPROLIS® (Carfilzomib), in Combination with Dexamethasone, Receives NICE Recommendation for Use at First Relapse

- National Institute for Health and Care Excellence (NICE) Published a Final Appraisal Determination (FAD) in a Single Technology...